AdvaMed CEO Scott Whitaker appeared before the U.S. Senate Finance Committee today to continue to assert that medtech deserves tariff exemptions in trade negotiations. “To be clear, we applaud the president’s efforts to bring more manufacturing back the United States and fix some of the existing trade imbalances, but the reality is, up to 70% […]
tariffs
Enovis stock down on reduced earnings forecast, $20M tariff impact
Enovis beat earnings expectations in its first quarter 2025 results, but its stock was down. The company, one of the largest orthopedic device companies in the world, is wading through the impact of tariffs, resulting in a lowered forecast for 2025 adjusted EBITDA. [Go here for a free download of our Orthopedic Device Industry Special Report.] […]
Siemens Healthineers expects up to €300 million in tariff costs
German medtech giant Siemens Healthineers (FRA: SHL) reduced the lower end of its full-year earnings guidance amid Trump administration tariffs. During an earnings call with analysts yesterday, CEO Bernhard Montag said the most significant impact of the tariffs was on imports from Europe into the U.S., while only very selective parts of the company’s portfolio […]
U.S.-China trade war could cost Philips up to €300M
Philips (NYSE: PHG) stock is down today after the company said tariffs between the U.S. and China (and the rest of the world) will have a €250–300 million impact this year. The Dutch medtech giant stuck with its comparable sales growth of 1–3%, but it reduced its adjusted EBITA margin range for the year to […]
Stryker posts strong Q1 results, expects $200M tariff costs
Stryker reported Street-beating financial results and increased its full-year sales forecast, but decreased its profitability guidance due to the Trump Administration’s new import taxes. SYK shares were down more than 2% to $365.56 apiece in morning trading today, the day after the company’s after-hour earnings release. The Portage, Michigan–based orthopedic and surgical device manufacturer reported […]
Baxter beats the Street in Q1, increases full-year guidance
Baxter today reported first quarter results that exceeded expectations. The Deerfield, Illinois–based medtech company reported sales of $2.63 billion for the first quarter (ended March 31), up 5% from the same quarter a year ago. Adjusted earnings per share (EPS) came in at $0.55. Those results beat Wall Street analysts’ expectations for adjusted EPS of […]
Facing up to $300M in tariff costs, Cardinal Health lays off employees
Cardinal Health said today that new import taxes could cost the company up to $300 million, and that it has already held layoffs as one response. Dublin, Ohio-based Cardinal Health — the world’s ninth-largest medical device company, according to Medical Design & Outsourcing‘s 2024 Medtech Big 100 ranking — said those tariff costs will mostly […]
GE HealthCare lowers its EPS guidance amid tariffs
GE HealthCare today announced Q1 results that beat the Wall Street analyst consensus — but it lowered its full-year EPS guidance due to the U.S.-China trade war and other tariff impacts. The Chicago-based medtech giant earned $588 million, or $1.23 per share, off of $4.8 billion for the quarter that ended March 31, 2025. The […]
Boston Scientific says sales could grow up to 17% this year
Boston Scientific stock is up as company officials predict that the ongoing trade war won’t hinder double-digit sales growth this year. The news of upped full-year guidance — which also included Street-beating first quarter results — sent shares of BSX rose more than 5% to $100.28 apiece in morning trading today. (The S&P 500 was […]
Intuitive expects tariffs to impact revenue by 1.7%
Intuitive Surgical is warning that President Donald Trump’s import taxes and retaliation from trade partners could have a significant impact. Yesterday evening, ISGR stock was down about 2% after-hours on the announcement, which also included Street-beating first-quarter results. By midday today, however, the stock was up more than 3% to $495.23 per share as […]
Abbott sticks by its full-year guidance amid trade war
Abbott today reported first quarter results that beat the Wall Street analyst consensus on earnings but missed on revenue. The Abbott Park, Illinois–based developer of medtech, diagnostics, and more stuck by its 2025 guidance amid economic turmoil from the Trump administration’s unpredictable global trade moves. Company leaders highlighted the company’s diverse business model, saying it […]
